SCA
Sage Capital Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.28M | Buy |
23,060
+247
| +1% | +$45.8K | 1.06% | 32 |
|
|
2025
Q1 | $4.78M | Buy |
22,813
+197
| +0.9% | +$41.3K | 1.25% | 29 |
|
|
2024
Q4 | $4.02M | Buy |
22,616
+161
| +0.7% | +$28.6K | 1.05% | 35 |
|
|
2024
Q3 | $4.43M | Buy |
22,455
+3,212
| +17% | +$634K | 1.16% | 27 |
|
|
2024
Q2 | $3.3M | Buy |
19,243
+332
| +2% | +$56.9K | 0.95% | 37 |
|
|
2024
Q1 | $3.44M | Buy |
18,911
+49
| +0.3% | +$8.92K | 1% | 38 |
|
|
2023
Q4 | $2.92M | Buy |
18,862
+319
| +2% | +$49.4K | 0.94% | 37 |
|
|
2023
Q3 | $2.76M | Buy |
18,543
+469
| +3% | +$69.9K | 1.01% | 37 |
|
|
2023
Q2 | $2.44M | Buy |
18,074
+2,063
| +13% | +$278K | 0.85% | 41 |
|
|
2023
Q1 | $2.55M | Buy |
16,011
+283
| +2% | +$45.1K | 0.97% | 36 |
|
|
2022
Q4 | $2.54M | Sell |
15,728
-36
| -0.2% | -$5.82K | 1.12% | 31 |
|
|
2022
Q3 | $2.12M | Sell |
15,764
-890
| -5% | -$119K | 1.08% | 31 |
|
|
2022
Q2 | $2.55M | Sell |
16,654
-5
| -0% | -$766 | 1.22% | 28 |
|
|
2022
Q1 | $2.92M | Sell |
16,659
-26,961
| -62% | -$4.72M | 1.18% | 30 |
|
|
2021
Q4 | $5.9M | Buy |
43,620
+2,682
| +7% | +$363K | 2.24% | 10 |
|
|
2021
Q3 | $4.42M | Buy |
40,938
+461
| +1% | +$49.7K | 1.88% | 20 |
|
|
2021
Q2 | $4.74M | Buy |
40,477
+2,890
| +8% | +$338K | 1.93% | 16 |
|
|
2021
Q1 | $4.07M | Sell |
37,587
-27
| -0.1% | -$2.92K | 1.82% | 21 |
|
|
2020
Q4 | $4.08M | Buy |
37,614
+67
| +0.2% | +$7.27K | 2.01% | 14 |
|
|
2020
Q3 | $3.29M | Buy |
37,547
+15,279
| +69% | +$1.34M | 2.01% | 13 |
|
|
2020
Q2 | $2.19M | Buy |
22,268
+4
| +0% | +$393 | 1.4% | 24 |
|
|
2020
Q1 | $1.7M | Buy |
+22,264
| New | +$1.7M | 1.39% | 22 |
|
|
2018
Q3 | – | Sell |
-18,009
| Closed | -$1.67M | – | 87 |
|
|
2018
Q2 | $1.67M | Buy |
+18,009
| New | +$1.67M | 1.17% | 29 |
|